Sl Science(NASDAQ) SLBT

Market Cap$846.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-85%
5 YearN/A
1 YearN/A
1 Month-26%
$1.51
+0.00%
+0.00Today
After hours$1.52+$0.01 (+0.66%)
Sl Science last closing stock price
MetricPriceDate
Last closeUSD 1.532026-10-13
Sl Science stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.66%USD 1.522026-10-06
1 month-25.73%USD 2.062026-09-11
3 month-63.92%USD 4.242026-07-15
Since inception-84.93%USD 10.022025-02-05

Sl Science Financials at a Glance

Market Cap

$846.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

6.21 (High)

Price

$1.51

Volume

121,164

Open

$1.49

Previous Close

$1.53

Daily Range

$1.49 - $1.59

52-Week Range

$1.42 - $14.50

Estimated Earnings Date

N/A

SLBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sl Science

SL Science Holding Ltd specializes in the manufacture of innovative cosmetic skin care and scalp care products. The company is recognized for its unique offerings, including milk-derived exosome essence and tangerine-derived extracts, aimed at enhancing skin health.

Products and Services
  • MilkExo concentrate series for skin rejuvenation
  • SL bio’s tangerine-derived extract for skin nourishment
  • Research services in advanced T-cell therapies
Growth Outlook
  • Projected market growth in the skincare sector is expected to reach $200 billion by 2026
  • Increased consumer demand for natural and effective skincare solutions
  • Expansion into new markets anticipated to drive revenue growth
Financial Highlights
  • Recent quarterly cash and cash equivalents totaled $1,258,616
  • Current ratio stands at 3.05, indicating strong liquidity
  • Trailing twelve months revenue of $1,000,000 with a gross profit margin of 35.27%
SL Science Holding Ltd is positioned within the biotechnology industry, focusing on innovative skincare solutions. The company has demonstrated a commitment to research and development, particularly in the area of T-cell therapies, which may enhance its product offerings and market reach. The skincare market is experiencing significant growth, driven by consumer preferences for natural ingredients, which aligns with the company's product line. Recent financial data indicates a solid liquidity position, with a current ratio of 3.05, suggesting the ability to meet short-term obligations effectively. The gross profit margin of 35.27% reflects the potential for profitability as the company scales its operations. Overall, SL Science Holding Ltd presents an intriguing opportunity for investors interested in the biotechnology and skincare sectors.
AI Generated • Sep 16, 2026

Industry

Biotechnology

Sector

Health Care

CEO

William Wang

Website

www.slbtgroup.com

Headquarters

Taipei, NY 115010, US

SLBT Financials

Key Financial Metrics (TTM)

Gross Margin

35.27%

Operating Margin

-174.65%

Net Income Margin

-173.85%

Return on Equity

-95.36%

Return on Capital

-153.66%

Return on Assets

-135.59%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$846.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

560.76M

Volume

121.16K

Avg. Volume

78.52K

Financials (TTM)

Gross Profit

$775.06K

Operating Income

-$3.84M

EBITDA

-$3.74M

Operating Cash Flow

-$1.91M

Capital Expenditure

-$319.69K

Free Cash Flow

-$2.23M

Cash & ST Invst.

$1.26M

Total Debt

$213.41K

Sl Science Performance Analysis

Sl Science annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20252025-12-31USD 0N/A
Sl Science sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31N/A
Q22025-06-30N/A
Q42025-12-31N/A
Sl Science annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20252025-12-31USD 0.00N/A
Sl Science sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31N/A
Q22025-06-30N/A
Q42025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$846.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACRSAclaris Therapeutics, Inc.
$3.47-3.61%
OCSOculis Holding AG
$7.62-3.30%
TTRXTurn Therapeutics Inc.
$10.60-4.59%
SLGLSol-Gel Technologies Ltd.
$68.30-5.66%

Trending Stocks

Symbol / CompanyPricePrice Chg
CIFRCipher Digital
$11.34-12.77%
BMBLBumble
$5.95+56.58%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$37.42+0.62%
INTCIntel
$102.81+1.44%

Questions About SLBT

What is the current price of Sl Science?

Sl Science is trading at $1.53 per share.

What is the 52-week range for Sl Science?

Over the past 52 weeks, Sl Science has traded between $1.42 and $14.50.

How much debt does Sl Science have?

As of the most recent reporting period, Sl Science reported total debt of $0.00.

How much cash does Sl Science have on hand?

Sl Science reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Sl Science’s dividend yield?

Sl Science does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services